Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma.
about
The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateTATN-1 mutations reveal a novel role for tyrosine as a metabolic signal that influences developmental decisions and longevity in Caenorhabditis elegansTyrosine aminotransferase: biochemical and structural properties and molecular dynamics simulationsIntracellular growth is dependent on tyrosine catabolism in the dimorphic fungal pathogen Penicillium marneffeiOSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma.Small nucleolar RNA 113-1 suppresses tumorigenesis in hepatocellular carcinomaHepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesisCMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinomaAneuploidy as a mechanism for stress-induced liver adaptation.Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.Phenotypic regulation of liver cells in a biofunctionalized three-dimensional hydrogel platform.Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma.PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinoma.CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.Metallothionein 1M suppresses tumorigenesis in hepatocellular carcinoma.Clinical significance of CMTM4 expression in hepatocellular carcinoma.Research on the hepatotoxicity mechanism of citrate-modified silver nanoparticles based on metabolomics and proteomics.
P2860
Q27003050-52031A8D-454C-4971-AAB8-DE0D2D286E05Q27318316-F93284CE-B989-4528-AB6F-83F4AA55FB05Q27666294-9011E048-22AD-4BD1-8773-D79B4A794033Q28545050-53228A69-A77A-4822-BA3C-9A659E526D42Q33728210-B8CC3A8B-6567-48E7-B2DE-9841B32901B9Q34217385-0C98CB60-C05A-42E2-B563-052810544595Q34265010-230E6273-011C-4D8A-AD69-99439F49CF14Q36172132-39310CB1-E8C5-4A3F-A836-39ACCC53BD4CQ36190750-A0050D19-31E9-41A9-B5E7-44392A7ACF2EQ38774648-82370F98-1E34-4D17-A5ED-E8EFF1F3A1C7Q38801232-C47F32FD-C735-4965-9D9B-39EE666C2ECFQ39629883-87BA5E68-9D94-42E3-8263-2B02B75800C3Q40088346-DA06E4BE-9154-4DAE-9EC7-7BB10BA4A1CEQ41757805-438128DB-58D6-4196-953B-501F1BF81BEFQ42212638-722DECF0-8766-4746-80CB-00732DAE7EF3Q45067272-84F86F2E-071E-4E1C-89AF-0D09E9D67AD0Q47282389-14C055A3-1330-44D1-8FF2-A7E3C79C599C
P2860
Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Down-regulation of tyrosine am ...... s of hepatocellular carcinoma.
@en
Down-regulation of tyrosine am ...... s of hepatocellular carcinoma.
@nl
type
label
Down-regulation of tyrosine am ...... s of hepatocellular carcinoma.
@en
Down-regulation of tyrosine am ...... s of hepatocellular carcinoma.
@nl
prefLabel
Down-regulation of tyrosine am ...... s of hepatocellular carcinoma.
@en
Down-regulation of tyrosine am ...... s of hepatocellular carcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Down-regulation of tyrosine am ...... is of hepatocellular carcinoma
@en
P2093
Kar Lok Kong
Lai-Shan Tai
Sui-Sui Dong
Yingduan Cheng
P2860
P304
P356
10.1002/HEP.23540
P407
P577
2010-05-01T00:00:00Z